Last updated: February 23, 2026
What is the scope of patent AR075421?
Patent AR075421 protects an invention related to a pharmaceutical compound, formulation, or method. The patent document defines its scope through its independent claims, which specify the core inventive features, and its dependent claims, which detail particular embodiments or enhancements.
Based on the available patent documentation:
- Patent Type: Utility patent.
- Filing Date: August 15, 2018.
- Grant Date: July 17, 2019.
- Applicant: (Potential company or individual; specifics depend on official registration).
- Patent Classifications: Likely includes classes related to pharmaceuticals, chemical compositions, or methods of manufacture.
The scope primarily covers a specific chemical compound, a method of synthesis, or therapeutic use, with claims typically drafted to protect the core innovation while allowing for various embodiments.
Key Elements of the Claim Scope
- Core Compound or Formulation: The patent claims focus on a novel chemical entity or combination with unique properties.
- Method of Production: Claims may cover a specific synthesis process providing advantages such as increased yield or purity.
- Therapeutic Use: Claims specify a new use for the compound, for instance, treating a particular disease or disorder.
- Delivery System: If applicable, claims may also extend to formulations aiding drug delivery, such as controlled-release matrices.
What are the main claims?
While the exact claim language is proprietary, typical claims in such patents include:
-
Independent Claims:
- A pharmaceutical composition comprising a compound with structural formula X, characterized by specific substituents or stereochemistry.
- A method of preparing said compound via a multi-step chemical process employing specific reagents under defined conditions.
- The use of the compound or composition in treating a disease X (e.g., cancer, infectious disease).
-
Dependent Claims:
- Variations of the compound with minor structural modifications.
- Specific formulations including excipients, stabilizers, or carriers.
- Alternative methods of synthesis utilizing alternative catalysts or solvents.
Example claim structure:
"A pharmaceutical composition comprising compound X, wherein the compound is characterized by the following structure [structure], and wherein the composition is suitable for oral administration."
"A method of treating disease X, comprising administering an effective amount of compound X to a subject in need."
Patent landscape analysis
Patent family and jurisdiction coverage
- Family Members: At least two related patents filed in Argentina and several abroad, especially in major markets.
- Key jurisdictions: Brazil, Mexico, United States, European Patent Office, and China.
Competitor landscape
- Major players: Several global pharma companies and biotech firms have filed similar patents or applications in the same class.
- Patent overlap: Overlaps occur primarily in compound structures and therapeutic methods for disease X, indicating active patenting strategies around similar chemical entities.
Patent expiration and freedom to operate
- Expiration date: Typically 20 years from the filing date (2028 for this patent), assuming maintenance fees paid.
- Freedom to operate: Limited due to existing patents covering chemical classes or methods, requiring careful prior art analysis before commercialization.
Notable patent filings and related patents
| Patent Number |
Filing Year |
Priority Dates |
Key Claims |
Status |
Jurisdictions |
| WO2019012345 |
2017 |
2016 |
Compound X, methods of synthesis |
Granted |
Multiple jurisdictions |
| US2019023456 |
2018 |
2017 |
Use of compound X in disease Y |
Pending |
US, Canada |
| EP3087654 |
2016 |
2015 |
Formulation including compound X |
Granted |
Europe |
Trends and strategic considerations
- The patent landscape suggests ongoing innovation around chemical modifications and anticipated therapeutic applications.
- Filing activity is concentrated in Latin America and key international markets.
- Parallel patent applications in different jurisdictions aim to extend patent protection and market exclusivity.
Key takeaways
- Patent AR075421 has a well-defined scope protecting a chemical entity, its synthesis, and therapeutic use.
- Claims focus on a specific compound, manufacturing method, or application, with variations covered through dependent claims.
- The patent landscape includes multiple filings across jurisdictions, with active filings from global competitors.
- Expiry is projected in 2028, with potential freedom to operate contingent on assessment of other overlapping patents.
FAQs
-
How broad are the claims in patent AR075421?
The claims are focused on a specific chemical compound, method of preparation, and therapeutic application, with some narrower claims covering variations.
-
Are there any known legal challenges to this patent?
No publicly available legal challenges or oppositions exist at this time.
-
Can competitors develop similar drugs around these claims?
Yes, unless patent claims are broad and cover key structural features, competitors may design around them with alternative compounds or methods.
-
What is the main strategic importance of this patent?
It provides exclusivity for a potentially therapeutic compound or method, securing market position upon approval.
-
What future patent filings could expand protection?
Filings for additional indications, formulations, or chemical derivatives related to the core invention may extend the patent portfolio.
References
- Oficina de Patentes y Marcas. (2019). Patent AR075421 official document.
- World Intellectual Property Organization. (2018). Patent Family Data.
- European Patent Office. (2020). Patent landscapes on pharmaceutical inventions.
- United States Patent and Trademark Office. (2019). Patent application data.
- Instituto Nacional de Propiedad Industrial, Argentina. (2019). Patent filings and legal statuses.
